4//SEC Filing
Semigran Marc 4
Accession 0001562180-23-006453
CIK 0001710072other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 7:13 PM ET
Size
5.5 KB
Accession
0001562180-23-006453
Insider Transaction Report
Form 4
Semigran Marc
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-17+133,333→ 133,333 totalExercise: $7.08Exp: 2033-08-17→ Common Stock (133,333 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date.
Documents
Issuer
Edgewise Therapeutics, Inc.
CIK 0001710072
Entity typeother
Related Parties
1- filerCIK 0001691494
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 7:13 PM ET
- Size
- 5.5 KB